PRA Health Sciences Company Profile (NASDAQ:PRAH)

About PRA Health Sciences (NASDAQ:PRAH)

PRA Health Sciences logoPRA Health Sciences, Inc. is a contract research organization. The Company provides outsourced clinical development services to the biotechnology and pharmaceutical industries. The Company offers therapeutic services in areas of pharmaceutical development, including oncology, central nervous system, inflammation and infectious diseases. Its services include data management, statistical analysis, clinical trial management, and regulatory and drug development consulting. It provides its clients with clinical development service offerings, which includes both traditional, project-based Phase I through Phase IV services, as well as embedded and functional outsourcing services. As of December 31, 2016, its clinical development platform included approximately 70 offices across North America, Europe, Asia, Latin America, South Africa, Australia and the Middle East. The Company's service offerings include product registration, strategic solutions and early development services.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology & Medical Research - NEC
  • Sub-Industry: N/A
  • Symbol: NASDAQ:PRAH
  • CUSIP: N/A
  • Web: www.prahs.com
Capitalization:
  • Market Cap: $4.79845 billion
  • Outstanding Shares: 62,471,000
Average Prices:
  • 50 Day Moving Avg: $74.86
  • 200 Day Moving Avg: $65.86
  • 52 Week Range: $43.41 - $79.98
P/E:
  • Trailing P/E Ratio: 44.12
  • Foreward P/E Ratio: 20.81
  • P/E Growth: 1.31
Sales & Book Value:
  • Annual Revenue: $1.63 billion
  • Price / Sales: 2.83
  • Book Value: $12.45 per share
  • Price / Book: 5.93
Profitability:
  • EBIDTA: $262.56 million
  • Net Margins: 5.85%
  • Return on Equity: 21.87%
  • Return on Assets: 7.30%
Debt:
  • Debt-to-Equity Ratio: 1.01%
  • Current Ratio: 1.16%
  • Quick Ratio: 1.16%
Misc:
  • Average Volume: 444,205 shs.
  • Beta: 0.48
  • Short Ratio: 2.21
 
Frequently Asked Questions for PRA Health Sciences (NASDAQ:PRAH)

What is PRA Health Sciences' stock symbol?

PRA Health Sciences trades on the NASDAQ under the ticker symbol "PRAH."

How were PRA Health Sciences' earnings last quarter?

PRA Health Sciences, Inc. (NASDAQ:PRAH) released its quarterly earnings data on Wednesday, November, 2nd. The company reported $0.64 earnings per share for the quarter, hitting the consensus estimate of $0.64. The company had revenue of $399.80 million for the quarter, compared to analyst estimates of $394.87 million. PRA Health Sciences had a net margin of 5.85% and a return on equity of 21.87%. PRA Health Sciences's revenue for the quarter was up 15.9% compared to the same quarter last year. During the same period in the previous year, the business earned $0.52 EPS. View PRA Health Sciences' Earnings History.

Where is PRA Health Sciences' stock going? Where will PRA Health Sciences' stock price be in 2017?

6 analysts have issued 1-year price objectives for PRA Health Sciences' shares. Their predictions range from $63.00 to $90.00. On average, they anticipate PRA Health Sciences' stock price to reach $78.20 in the next twelve months. View Analyst Ratings for PRA Health Sciences.

Are investors shorting PRA Health Sciences?

PRA Health Sciences saw a decrease in short interest in the month of June. As of June 15th, there was short interest totalling 812,245 shares, a decrease of 24.7% from the May 31st total of 1,078,213 shares. Based on an average daily trading volume, of 378,549 shares, the short-interest ratio is presently 2.1 days. Currently, 2.0% of the shares of the company are sold short.

Who are some of PRA Health Sciences' key competitors?

Who are PRA Health Sciences' key executives?

PRA Health Sciences' management team includes the folowing people:

  • Colin Shannon, Chairman of the Board, President, Chief Executive Officer
  • Linda Baddour, Chief Financial Officer, Executive Vice President
  • David W. Dockhorn Ph.D., Executive Vice President, Corporate Compliance Officer
  • Max C. Lin, Director
  • James C. Momtazee, Director
  • Ali J. Satvat, Director
  • Jeffrey T. Barber, Independent Director
  • Linda S. Grais M.D., Independent Director

When did PRA Health Sciences IPO?

(PRAH) raised $306 million in an IPO on Thursday, November 13th 2014. The company issued 17,000,000 shares at a price of $18.00 per share. Jefferies, Citigroup, KKR, UBS Investment Bank, Credit Suisse and Wells Fargo Securities served as the underwriters for the IPO and Baird and William Blair were co-managers.

Who owns PRA Health Sciences stock?

PRA Health Sciences' stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Acadian Asset Management LLC (3.13%), Russell Investments Group Ltd. (1.42%), Harbour Capital Advisors LLC (0.77%), Vaughan Nelson Investment Management L.P. (0.77%), Bellecapital International Ltd. (0.12%) and Meritage Portfolio Management (0.11%). Company insiders that own PRA Health Sciences stock include Colin Shannon, David W Dockhorn, Linda Baddour and Pra Investors LP Kkr. View Institutional Ownership Trends for PRA Health Sciences.

Who sold PRA Health Sciences stock? Who is selling PRA Health Sciences stock?

PRA Health Sciences' stock was sold by a variety of institutional investors in the last quarter, including Acadian Asset Management LLC, Insight Capital Research & Management Inc., Vaughan Nelson Investment Management L.P., Bank of Montreal Can, KAMES CAPITAL plc, NGAM Advisors L.P., Independent Portfolio Consultants Inc. and Meritage Portfolio Management. Company insiders that have sold PRA Health Sciences stock in the last year include Colin Shannon, David W Dockhorn and Linda Baddour. View Insider Buying and Selling for PRA Health Sciences.

Who bought PRA Health Sciences stock? Who is buying PRA Health Sciences stock?

PRA Health Sciences' stock was purchased by a variety of institutional investors in the last quarter, including Harbour Capital Advisors LLC, Russell Investments Group Ltd., Bellecapital International Ltd., Legato Capital Management LLC, Parametrica Management Ltd, Aperio Group LLC, Chase Investment Counsel Corp and Strs Ohio. View Insider Buying and Selling for PRA Health Sciences.

How do I buy PRA Health Sciences stock?

Shares of PRA Health Sciences can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is PRA Health Sciences' stock price today?

One share of PRA Health Sciences stock can currently be purchased for approximately $73.86.


MarketBeat Community Rating for PRA Health Sciences (NASDAQ PRAH)
Community Ranking:  3.0 out of 5 (  )
Outperform Votes:  124 (Vote Outperform)
Underperform Votes:  83 (Vote Underperform)
Total Votes:  207
MarketBeat's community ratings are surveys of what our community members think about PRA Health Sciences and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for PRA Health Sciences (NASDAQ:PRAH) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Hold Rating, 5 Buy Ratings
Consensus Rating:Buy (Score: 2.83)
Consensus Price Target: $78.20 (5.88% upside)

Analysts' Ratings History for PRA Health Sciences (NASDAQ:PRAH)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
6/28/2017Citigroup Inc.Reiterated RatingBuy$73.00 -> $90.00LowView Rating Details
6/26/2017Bank of America CorporationInitiated CoverageBuy$89.00LowView Rating Details
6/6/2017Credit Suisse GroupReiterated RatingOutperform$69.00 -> $76.00LowView Rating Details
6/1/2017Jefferies Group LLCSet Price TargetBuy$73.00LowView Rating Details
2/27/2017Avondale PartnersUpgradeUnderperform -> Market Perform$63.00N/AView Rating Details
11/4/2016KeyCorpReiterated RatingBuyN/AView Rating Details
6/20/2016First AnalysisInitiated CoverageEqual -> Equal Weight$47.00N/AView Rating Details
3/28/2016SunTrust Banks, Inc.UpgradeNeutral -> Buy$47.00 -> $51.00N/AView Rating Details
11/3/2015Robert W. BairdBoost Price TargetOutperform$47.00 -> $49.00N/AView Rating Details
8/21/2015William BlairReiterated RatingOutperformN/AView Rating Details
(Data available from 7/28/2015 forward)

Earnings

Earnings History for PRA Health Sciences (NASDAQ:PRAH)
Earnings by Quarter for PRA Health Sciences (NASDAQ:PRAH)
Earnings History by Quarter for PRA Health Sciences (NASDAQ PRAH)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/25/2017Q1 2017$0.58$0.60$426.81 million$427.08 millionViewN/AView Earnings Details
2/22/2017Q4 2016$0.64$0.71$405.04 million$413.61 millionViewN/AView Earnings Details
11/2/2016Q316$0.64$0.64$394.87 million$399.80 millionViewN/AView Earnings Details
7/28/2016Q2$0.59$0.63$381.25 million$394.20 millionViewListenView Earnings Details
4/27/2016Q116$0.53$0.55$372.21 million$372.30 millionViewListenView Earnings Details
2/24/2016Q4$0.49$0.59$353.42 million$428.90 millionViewListenView Earnings Details
11/2/2015Q3$0.45$0.52$346.05 million$345.10 millionViewListenView Earnings Details
7/27/2015Q215$0.40$0.47$336.74 million$336.50 millionViewListenView Earnings Details
5/6/2015Q115$0.31$0.41$329.80 million$332.00 millionViewListenView Earnings Details
2/18/2015Q414$0.30$0.35$323.50 million$370.00 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for PRA Health Sciences (NASDAQ:PRAH)
2017 EPS Consensus Estimate: $3.01
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20172$0.57$0.66$0.62
Q2 20173$0.68$0.79$0.73
Q3 20173$0.80$0.81$0.81
Q4 20173$0.77$0.93$0.86
(Data provided by Zacks Investment Research)

Dividends

Dividend History for PRA Health Sciences (NASDAQ:PRAH)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for PRA Health Sciences (NASDAQ:PRAH)
Insider Ownership Percentage: 2.10%
Insider Trades by Quarter for PRA Health Sciences (NASDAQ:PRAH)
Institutional Ownership by Quarter for PRA Health Sciences (NASDAQ:PRAH)
Insider Trades by Quarter for PRA Health Sciences (NASDAQ:PRAH)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/17/2017Linda BaddourVPSell196,393$63.59$12,488,630.87View SEC Filing  
3/28/2017Colin ShannonCEOSell50,000$64.00$3,200,000.00View SEC Filing  
3/27/2017David W DockhornInsiderSell85,182$62.00$5,281,284.00View SEC Filing  
2/23/2017Colin ShannonCEOSell100,000$61.50$6,150,000.00View SEC Filing  
8/22/2016Colin ShannonCEOSell113,133$51.57$5,834,268.81View SEC Filing  
8/15/2016Linda BaddourVPSell69,380$52.00$3,607,760.00View SEC Filing  
8/12/2016David W. DockhornVPSell107,257$49.00$5,255,593.00View SEC Filing  
5/6/2016Linda BaddourCFOSell92,308$46.70$4,310,783.60View SEC Filing  
5/6/2016Pra Investors L.P. KkrMajor ShareholderSell4,907,692$46.70$229,189,216.40View SEC Filing  
3/8/2016Colin ShannonCEOSell77,019$42.26$3,254,822.94View SEC Filing  
3/8/2016Linda BaddourCFOSell93,000$42.26$3,930,180.00View SEC Filing  
3/8/2016Pra Investors L.P. KkrMajor ShareholderSell4,829,981$42.26$204,114,997.06View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for PRA Health Sciences (NASDAQ:PRAH)
Latest Headlines for PRA Health Sciences (NASDAQ:PRAH)
Source:
DateHeadline
seekingalpha.com logoPRA Health Sciences Set For A Quarterly Earnings Surprise - Again
seekingalpha.com - July 27 at 6:31 AM
finance.yahoo.com logoPRA Health Sciences to Report 2nd Quarter 2017 Earnings
finance.yahoo.com - July 26 at 6:30 AM
americanbankingnews.com logo$447.88 Million in Sales Expected for PRA Health Sciences, Inc. (NASDAQ:PRAH) This Quarter
www.americanbankingnews.com - July 19 at 3:02 PM
americanbankingnews.com logoPRA Health Sciences, Inc. (PRAH) Expected to Post Earnings of $0.72 Per Share
www.americanbankingnews.com - July 17 at 11:29 AM
americanbankingnews.com logoPRA Health Sciences, Inc. (PRAH) Receives Consensus Rating of "Buy" from Brokerages
www.americanbankingnews.com - July 11 at 2:32 PM
americanbankingnews.com logoPRA Health Sciences, Inc. (PRAH) Sees Significant Drop in Short Interest
www.americanbankingnews.com - July 1 at 7:10 AM
americanbankingnews.com logoPRA Health Sciences, Inc. (PRAH) Rating Reiterated by Citigroup Inc.
www.americanbankingnews.com - June 28 at 12:40 PM
americanbankingnews.com logoPRA Health Sciences, Inc. (PRAH) Receives New Coverage from Analysts at Bank of America Corporation
www.americanbankingnews.com - June 26 at 12:16 PM
americanbankingnews.com logo$447.60 Million in Sales Expected for PRA Health Sciences, Inc. (PRAH) This Quarter
www.americanbankingnews.com - June 23 at 5:54 PM
americanbankingnews.com logo$0.72 Earnings Per Share Expected for PRA Health Sciences, Inc. (PRAH) This Quarter
www.americanbankingnews.com - June 21 at 7:34 AM
finance.yahoo.com logoPRA Health Sciences and Jumo Announce Partnership
finance.yahoo.com - June 19 at 10:18 AM
americanbankingnews.com logoPRA Health Sciences, Inc. (PRAH) Receives Average Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - June 16 at 1:08 PM
americanbankingnews.com logoShort Interest in PRA Health Sciences, Inc. (PRAH) Drops By 25.6%
www.americanbankingnews.com - June 14 at 7:14 AM
americanbankingnews.com logoPRA Health Sciences' (PRAH) Outperform Rating Reaffirmed at Credit Suisse Group AG
www.americanbankingnews.com - June 6 at 3:38 PM
americanbankingnews.com logoZacks: Brokerages Expect PRA Health Sciences Inc (PRAH) Will Post Quarterly Sales of $447.6 Million
www.americanbankingnews.com - May 28 at 10:46 AM
americanbankingnews.com logoPRA Health Sciences Inc (PRAH) Sees Large Increase in Short Interest
www.americanbankingnews.com - May 28 at 9:06 AM
americanbankingnews.com logo Analysts Expect PRA Health Sciences Inc (PRAH) Will Announce Earnings of $0.72 Per Share
www.americanbankingnews.com - May 26 at 10:11 AM
finance.yahoo.com logoPRA Health Sciences Named International Clinical Research Company of the Year
finance.yahoo.com - May 22 at 6:28 PM
americanbankingnews.com logoPRA Health Sciences Inc (PRAH) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - May 22 at 12:24 PM
americanbankingnews.com logoPRA Health Sciences Inc (PRAH) Short Interest Update
www.americanbankingnews.com - May 13 at 8:16 AM
finance.yahoo.com logoBiopharmaceutical Services Stock Continues To Test New Buy Zone
finance.yahoo.com - May 12 at 8:05 PM
streetinsider.com logoDelmar Pharma (DMPI) Formalizes Collaboration with PRA Health (PRAH) for Phase 3 Trial of VAL-083 in GBM
www.streetinsider.com - May 12 at 8:11 AM
nasdaq.com logoPRAH Crosses Above Average Analyst Target
www.nasdaq.com - May 12 at 8:11 AM
finance.yahoo.com logoDelMar Formalizes Collaboration with PRA Health Sciences for Phase 3 Trial of VAL-083 in Recurrent Glioblastoma Multiforme (GBM)
finance.yahoo.com - May 11 at 8:36 AM
finance.yahoo.com logoPRA Health Sciences Announces The Center for Pediatric Clinical Development
finance.yahoo.com - May 4 at 7:31 PM
americanbankingnews.com logoPRA Health Sciences Inc (PRAH) Expected to Announce Quarterly Sales of $447.6 Million
www.americanbankingnews.com - May 4 at 12:00 PM
americanbankingnews.com logoPRA Health Sciences (PRAH) Getting Favorable News Coverage, Analysis Shows
www.americanbankingnews.com - May 2 at 10:02 PM
americanbankingnews.com logo$0.73 Earnings Per Share Expected for PRA Health Sciences Inc (PRAH) This Quarter
www.americanbankingnews.com - May 2 at 8:00 PM
finance.yahoo.com logoPRA Health Sciences Named Clinical Research Company of the Year
finance.yahoo.com - May 2 at 10:09 AM
finance.yahoo.com logoETFs with exposure to PRA Health Sciences, Inc. : May 1, 2017
finance.yahoo.com - May 1 at 6:33 PM
americanbankingnews.com logoWilliam Blair Analysts Raise Earnings Estimates for PRA Health Sciences Inc (PRAH)
www.americanbankingnews.com - May 1 at 1:44 PM
americanbankingnews.com logoQ3 2017 Earnings Estimate for PRA Health Sciences Inc Issued By KeyCorp (PRAH)
www.americanbankingnews.com - May 1 at 8:54 AM
americanbankingnews.com logoQ2 2017 EPS Estimates for PRA Health Sciences Inc (PRAH) Decreased by Analyst
www.americanbankingnews.com - May 1 at 7:42 AM
americanbankingnews.com logoPRA Health Sciences (PRAH) Getting Favorable Press Coverage, Report Finds
www.americanbankingnews.com - April 29 at 4:47 PM
americanbankingnews.com logoPRA Health Sciences Inc (PRAH) Stock Rating Reaffirmed by Jefferies Group LLC
www.americanbankingnews.com - April 29 at 1:05 AM
americanbankingnews.com logoFY2017 EPS Estimates for PRA Health Sciences Inc Increased by William Blair (PRAH)
www.americanbankingnews.com - April 28 at 3:48 PM
finance.yahoo.com logoPRA Health Sciences, Inc. :PRAH-US: Earnings Analysis: Q1, 2017 By the Numbers : April 28, 2017
finance.yahoo.com - April 28 at 3:18 PM
finance.yahoo.com logoEdited Transcript of PRAH earnings conference call or presentation 26-Apr-17 1:00pm GMT
finance.yahoo.com - April 27 at 10:34 AM
prnewswire.com logoResearch Reports Initiation on Medical Research Stocks -- Alere, OpGen, Novadaq Technologies, and PRA Health
www.prnewswire.com - April 26 at 5:59 PM
seekingalpha.com logoPRA Health Sciences' (PRAH) CEO Colin Shannon on Q1 2017 Results - Earnings Call Transcript
seekingalpha.com - April 26 at 5:59 PM
americanbankingnews.com logoPRA Health Sciences (PRAH) Receives Daily Media Impact Rating of 0.56
www.americanbankingnews.com - April 26 at 3:34 PM
americanbankingnews.com logoPRA Health Sciences Inc (PRAH) Releases Quarterly Earnings Results, Beats Estimates By $0.02 EPS
www.americanbankingnews.com - April 25 at 10:06 PM
americanbankingnews.com logoPRA Health Sciences Inc (PRAH) Issues FY17 Earnings Guidance
www.americanbankingnews.com - April 25 at 7:40 PM
seekingalpha.com logoPRA Health Sciences beats by $0.02, beats on revenue
seekingalpha.com - April 25 at 6:25 PM
globenewswire.com logoPRA Health Sciences, Inc. Reports First Quarter 2017 Results
globenewswire.com - April 25 at 6:25 PM
marketbeat.com logoPRA Health Sciences beats Street 1Q forecasts
marketbeat.com - April 25 at 4:47 PM
americanbankingnews.com logoPRA Health Sciences Inc (PRAH) Given Consensus Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - April 25 at 12:33 PM
americanbankingnews.com logoPRA Health Sciences (PRAH) Receives Daily News Sentiment Rating of 0.44
www.americanbankingnews.com - April 23 at 12:58 PM
americanbankingnews.com logoPRA Health Sciences Inc (PRAH) VP Sells $12,488,630.87 in Stock
www.americanbankingnews.com - April 19 at 4:52 PM
americanbankingnews.com logoPRA Health Sciences (PRAH) Earning Very Positive News Coverage, Report Finds
www.americanbankingnews.com - April 19 at 10:27 AM

Social

Chart

PRA Health Sciences (PRAH) Chart for Friday, July, 28, 2017

This page was last updated on 7/28/2017 by MarketBeat.com Staff